title: Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis.
authors.forename: T
authors.initials: T
authors.lastname: Cobo Ibáñez
authors.forename: M
authors.initials: M
authors.lastname: Yehia Tayel
authors.forename: A
authors.initials: A
authors.lastname: Balsa Criado
authors.forename: A
authors.initials: A
authors.lastname: Hernández Sanz
authors.forename: E
authors.initials: E
authors.lastname: Martín Mola
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007555:Isoxazoles; D000069285:Infliximab; D000077339:Leflunomide; D008727:Methotrexate